רווח למניה בשנים עשר החודשים האחרונים: Simulations Plus Inc (SLP)

Simulations Plus, Inc. (SLP) dominates pricing power through AI-driven biochemistry modeling that reduces testing timelines. The rolling annual earnings per share trend on the GURU.Markets chart shows that the value of this metric is 0.40. Growing demand for biosimulations in biotech and an impeccable brand reputation among pharma behemoths secure the company's status as a global technological leader.

Net income per share over twelve months measures the issuer's actual ability to generate income per share, stripping the financial result of the influence of the total volume of shares outstanding. The growth in the rolling annual earnings per share confirms the high efficiency of the autonomous biochemical process simulation algorithms of Simulations Plus, Inc. (SLP), signaling business scalability and fundamental stability.